Maravai LifeSciences Holdings, Inc. Restructuring Charges
Maravai LifeSciences Holdings, Inc. (MRVI) reported Restructuring Charges of -$33.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-08-07
- Maravai LifeSciences Holdings, Inc. restructuring charges for the quarter ending 2026-06-30 was -$33.00K.
- Maravai LifeSciences Holdings, Inc. restructuring charges for the quarter ending 2026-03-31 was $2.88M.
- Maravai LifeSciences Holdings, Inc. restructuring charges for the quarter ending 2025-12-31 was $10.44M, a 173916.67% increase year-over-year.
- Maravai LifeSciences Holdings, Inc. restructuring charges for the quarter ending 2025-09-30 was $7.39M.
- Maravai LifeSciences Holdings, Inc. restructuring charges for fiscal 2025 was $17.83M.
- Maravai LifeSciences Holdings, Inc. restructuring charges for fiscal 2024 was -$1.21M, a 118.78% decline from fiscal 2023.
- Maravai LifeSciences Holdings, Inc. restructuring charges for fiscal 2023 was $6.47M.
- Maravai LifeSciences Holdings, Inc. restructuring charges for fiscal 2022 was $0.00.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$33.00K 10-Q · filed 2026-08-07 | $2.85M 10-Q · filed 2026-08-07 | $13.29M derived: sum of 3 quarters · filed 2026-08-07 | $20.67M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $2.88M 10-Q · filed 2026-05-08 | $13.32M derived: sum of 2 quarters · filed 2026-05-08 | $20.70M derived: sum of 3 quarters · filed 2026-05-08 | $20.70M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $10.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $17.83M derived: sum of 2 quarters · filed 2026-02-26 | $17.83M derived: sum of 3 quarters · filed 2026-08-07 | $17.83M 10-K · filed 2026-02-26 |
| 2025-09-30 | $7.39M 10-Q · filed 2025-11-07 | $7.39M derived: sum of 2 quarters · filed 2026-08-07 | $7.39M 10-Q · filed 2025-11-07 | $7.39M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-07 | $0.00 10-Q · filed 2026-08-07 | $6.00K derived: sum of 3 quarters · filed 2026-08-07 | $2.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-08 | $6.00K derived: sum of 2 quarters · filed 2026-05-08 | $2.00K derived: sum of 3 quarters · filed 2026-05-08 | -$2.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.00K derived: sum of 2 quarters · filed 2026-02-26 | -$2.00K derived: sum of 3 quarters · filed 2026-02-26 | -$1.21M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$4.00K 10-Q · filed 2025-11-07 | -$8.00K derived: sum of 2 quarters · filed 2025-11-07 | -$1.22M 10-Q · filed 2025-11-07 | $5.25M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$4.00K 10-Q · filed 2025-08-11 | -$1.22M 10-Q · filed 2025-08-11 | $5.25M derived: sum of 3 quarters · filed 2026-02-26 | $5.25M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$1.21M 10-Q · filed 2025-05-12 | $5.25M derived: sum of 2 quarters · filed 2026-02-26 | $5.25M derived: sum of 3 quarters · filed 2026-02-26 | $5.25M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $6.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.47M derived: sum of 2 quarters · filed 2026-02-26 | $6.47M derived: sum of 3 quarters · filed 2026-02-26 | $6.47M 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-03-18 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 |